Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Denali Therapeutics
Biotech
Denali ph. 1 Pompe plans hit with clinical hold
Denali does not expect the hold to delay its plans, and still intends to submit a clinical trial application in Europe in the first half of 2026.
Darren Incorvaia
Dec 4, 2025 11:52am
Royalty's $275M financing deal for Denali drug awaiting FDA nod
Dec 4, 2025 10:20am
Denali's Hunter syndrome drug latest to be hit by FDA delay
Oct 14, 2025 8:09am
Denali Alzheimer's antibody clears plaques without ARIA in mice
Aug 7, 2025 2:00pm
Blocking enzyme saved mice from known Parkinson’s mechanism
Jul 2, 2025 5:26pm
Denali’s ALS drug comes up short in trial extension
Mar 6, 2025 8:20am
